BCRX
BioCryst Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
3.86 / 10Overall Score
NeturalInvestment Rating
3.86 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of BCRX
- Based on a composite score of 3.86/10, we rate BCRX as a Netural. Our analysis breaks down into 2.31/10 for Fundamentals, 2.48/10 for Technicals, and 5.33/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of BCRX?
Is BCRX undervalued or overvalued?
Is money flowing into or out of BCRX?
Trend Analysis of BCRX
- Based on a composite score of 3.86/10, we rate BCRX as a Netural. Our analysis breaks down into 2.31/10 for Fundamentals, 2.48/10 for Technicals, and 5.33/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is BCRX undervalued or overvalued?
Technical Analysis of BCRX?
Is money flowing into or out of BCRX?
